Search
for
Sort by
Research 30 of 704
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Update on hidradenitis suppurativa: connecting the tracts
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- New developments in the molecular treatment of ichthyosis: review of the literature
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Alopecia Areata: Current Treatments and New Directions
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Efficacy and Safety of Biologic Therapies for Treatment of Psoriasis: A Systematic Review and Observational Meta-Analysis
- Editor's Picks
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment